Local anesthetics have a major impact on viability of preadipocytes and their differentiation into adipocytes

Plastic and Reconstructive Surgery

Volumn 126, Issue 5, 2010, Pages 1500-1505

  Keck, Maike ^a   Zeyda, Maximilian ^b   Gollinger, Karina ^b   Burjak, Sonja ^b   Kamolz, Lars Peter ^b   Frey, Manfred ^b   Stulnig, Thomas M ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADRENALIN; ARTICAINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEPIVACAINE;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; DRUG EFFECT; HUMAN; IN VITRO STUDY; PHYSIOLOGY; TRANSPLANTATION;

ADIPOCYTES; ADIPONECTIN; ADIPOSE TISSUE; ANESTHETICS, LOCAL; CARTICAINE; CELL DIFFERENTIATION; CELL SURVIVAL; EPINEPHRINE; HUMANS; LIDOCAINE; MEPIVACAINE;

EID: 78650176310     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181ef8beb     Document Type: Article

References (49)

1. Neuber F. Fetttransplantation. Zentralbl Chir. 1893;22:66.
2. Coleman SR. Long term survival of fat transplants: Controlled demonstrations. Aesthetic Plast Surg. 1995;9:421-425.
3. Coleman SR. Facial recontouring with lipostructure. Clin Plast Surg. 1997;24:347-367.
4. Glashofer M, Lawrence N. Fat transplantation for treatment of the senescent face. Dermatol Ther. 2006;19:169-176.
5. Carpaneda CA. Study of aspirated adipose tissue. Aesthetic Plast Surg. 1996;20:399-402.
6. Chajchir A, Benzaquen I. Fat-grafting injection for soft tissue augmentation. Plast Reconstr Surg. 1989;84:921-934.
7. Coleman SR. Structural fat grafting: More than a permanent filler. Plast Reconstr Surg. 2006;118:108-120.
8. Lewis CM. The current status of autologous fat grafting. Aesthetic Plast Surg. 1993;17:109-112.
9. Boschert MT, Beckert BW, Puckett CL, Concannon MJ. Analysis of lipocyte viability after liposuction. Plast Reconstr Surg. 2002;109:761-765.
10. Mikus JL, Koufman JA, Kilpatrick SE. Fate of liposuctioned and purified autologous fat injections in the canine vocal fold. Laryngoscope 1995;105:17-22.
11. Niechajev I, Sevcuk O. Long-term results of fat transplantation: Clinical and histologic studies. Plast Reconstr Surg. 1994; 94:496-506.
12. Peer LA. Loss of weight and volume in human fat grafts. Plast Reconstr Surg. 1991;15:321-326.
13. Toledo LS, Mauad R. Fat injection: A 20-year revision. Clin Plast Surg. 2006;33:47-53.
14. Smahel J. Experimental implantation of adipose tissue fragments. Br J Plast Surg. 1989;42:207-211.
15. Björntorp P, Karlsson M, Petterson P, Sypniekwska G. Differentiation and function of rat adipocyte precursor cells in primary culture. J Lipid Res. 1980;21:714-723.
16. Von Heimburg D, Kuberka M, Rendchen R, Hemmrich K, Rau G, Pallua N. Preadipocyte loaded collagen scaffolds with enlarged pore size for improved soft tissue engineering. Int J Artif Organs 2003;26:1064-1076.
17. Von Heimburg D, Zachariah S, Heschel I, et al. Human preadipocytes seeded on freeze-dried collagen scaffolds investigated in vitro and vivo. Biomaterials 2001;22:429-438.
18. Keck M, Haluza D, Burjak S, Eisenbock B, Kamolz LP, Frey M. Cultivation of keratinocytes and preadipocytes on a collagen- elastin scaffold (Matriderm): First results of an in vitro study. Eur Surg. 2009;41:189-193.
19. Rigotti G, Marchi A, Galiè M, et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: A healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg. 2007;119:1409-1422.
20. Serra-Renom JM, Muñoz-Olmo JL, Serra-Mestre JM. Fat grafting in postmastectomy breast reconstruction with expanders and prostheses in patients who have received radiotherapy: Formation of new subcutaneous tissue. Plast Reconstr Surg. 2010;125:12-18.
21. Keck M, Janke J, Ueberreiter K. Viability of preadipocytes in vitro: The influence of local anesthetics and pH. Dermatol Surg. 2009;35:1251-1257.
22. Körner A, Wabitsch M, Seidel B, et al. Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight. Biochem Biophys Res Commun. 2005;337: 540-550.
23. Coleman SR. Structural fat grafting: More than a permanent filler. Plast Reconstr Surg. 2006;118:108-120.
24. Smith P, Adams WP, Lipschitz AH, et al. Autologous human fat grafting: Effect of harvesting and preparation techniques on adipocyte graft survival. Plast Reconstr Surg. 2006;117:1836-1844.
25. Chang YS, Tseng SY, Tseng SH, Wu CL. Cytotoxicity of lidocaine or bupivacaine on corneal endothelial cells in a rabbit model. Cornea 2006;25:590-596.
26. Gerancher JC. Cauda equina syndrome following a single spinal administration of 5% hyperbaric lidocaine through a 25-gauge Whitacre needle. Anaesthesiology 1997;87:687-689.
27. Lambert LA, Lambert DH, Strichartz GR. Irreversible conduction block in isolated nerve by high concentrations of local anesthetics. Anesthesiology 1994;80:1082-1093.
28. Pollock JE. Neurotoxicity of intrathecal local anaesthetics and transient neurological symptoms. Best Pract Res Clin Anaesthesiol. 2003;17:471-484.
29. Sakaguchi M, Kuroda Y, Hirose M. The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor. Anesth Analg. 2006;102:1103-1107.
30. Punke MA, Friederich P. Lipophilic and stereospecific interactions of amino-amide local anesthetics with human Kv1.1 channels. Anesthesiology 2008;109:895-904.
31. Werdehausen R, Fazeli S, Braun S, et al. Apoptosis induction by different local anaesthetics in a neuroblastoma cell line. Br J Anaesth. 2009;103:711-718.
32. Oertel R, Rahn R, Kirch W. Clinical pharmacokinetics of articaine. Clin Pharmacokinet. 1997;33:417-425.
33. Johnson ME. Neurotoxicity of lidocaine: Implications for spinal anesthesia and neuroprotection. J Neurosurg Anesthesiol. 2004;16:80-83.
34. Lirk P, Haller I, Myers RR, et al. Mitigation of direct neurotoxic effects of lidocaine and amitriptyline by inhibition of p38 mitogen-activated protein kinase in vitro and in vivo. Anesthesiology 2006;104:1266-1273.
35. Hogan QH. Pathophysiology of peripheral nerve injury during regional anesthesia. Reg Anesth Pain Med. 2008;33:435-441.
36. Adade AB, Chignell D, Vanderkooi G. Local anesthetics: A new class of partial inhibitors of mitochondrial ATPase. J Bioenerg Biomembr. 1984;16:353-363.
37. Haller I, Hausott B, Tomaselli B, et al. Neurotoxicity of lidocaine involves specific activation of the p38 mitogen-activated protein kinase, but not extracellular signal-regulated or c-jun N-terminal kinases, and is mediated by arachidonic acid metabolites. Anesthesiology 2006;105:1024-1033.
38. Lirk P, Haller I, Colvin HP, et al. In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity. Anesth Analg. 2008;106:1456-1464.
39. Lirk P, Haller I, Colvin HP, et al. In vitro, lidocaine-induced axonal injury is prevented by peripheral inhibition of the p38 mitogen-activated protein kinase, but not by inhibiting caspase activity. Anesth Analg. 2007;105:1657-1064.
40. Sztark F, Ouhabi R, Dabadie P, Mazat JP. Effects of the local anesthetic bupivacaine on mitochondrial energy metabolism: Change from uncoupling to decoupling depending on the respiration state. Biochem Mol Biol Int. 1997;43:997-1003.
41. Tan Z, Dohi S, Chen J, Banno Y, Nozawa Y. Involvement of the mitogen-activated protein kinase family in tetracaineinduced PC12 cell death. Anesthesiology 2002;96:1191-1201.
42. Shoshani O, Berger J, Fodor L, et al. The effect of lidocaine and adrenaline on the viability of injected adipose tissue: An experimental study in nude mice. J Drugs Dermatol. 2005;44:311-316.
43. Beahm EK, Walton RL, PatrickCWJr. Progress in adipose tissue construct development. Clin Plast Surg. 2003;30:547-558.
44. Patrick CW, Mikos AG, McIntire LV. Frontiers in Tissue Engineering. 1st ed. New York: Pergamon; 1998.
45. Coleman SR, Saboeiro A. Fat grafting to the breast revisited: Safety and efficacy. Ann Plast Surg. 2007;119:775-785.
46. Kimura Y, Ozeki M, Inamoto T, Tabata Y. Time course of de novo adipogenesis in matrigel by gelatin microspheres incorporating basic fibroblast growth factor. Tissue Eng. 2002; 8:603-613.
47. Shetty S, Kusminski CM, Scherer PE. Adiponectin in health and disease: Evaluation of adiponectin-targeted drug development strategies. Trends Pharmacol Sci. 2009;30:234-239.
48. Mysore V, IADVL Dermatosurgery Task Force. Tumescent liposuction: Standard guidelines of care. Indian J Dermatol Venereol Leprol. 2008;74(Suppl):S54-S60.
49. Holvoet P, De Keyzer D, Jacobs DR Jr. Oxidized LDL and the metabolic syndrome. Future Lipidol. 2008;6:637-649.